SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ALZN

Alzamend Neuro, Inc. (NASDAQ:ALZN)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.78-$0.24 (-23.94%)
 
Market cap
$3.74M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 15, 2021
Market Cap$3.74M-62.7%
Revenue (ttm)$0
Net Income-$9.10M-45.7%
EPS-$2.30+74.5%
Shares Out4.83M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume93,127
Open$0.89
Previous Close$1.02
Day's Range$0.76 - $0.89
52-Week Range$0.75 - $2.54
Beta0.19
AnalystsBuy
Price Targetn/a
Earnings DateDec 8, 2026
-25.49% (1D)
No price history available.

About ALZN

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Address
3480 Peachtree Road NE, Atlanta, GA, 30326, US
Market Cap
4 million
Employees
6
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.36M
Bought
$330.83K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From ALZN’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-23.94%
5 Days
-36.93%
1 Month
-30.73%
6 Months
-31.35%
1 Year
-62.70%

$ALZN stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ALZN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ALZN's directors and management

Net Shares Purchased by Insiders−400k−200k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ALZN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ALZN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ALZN from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ALZN

VXFVanguard Extended Market ETF$43.81K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ALZN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
5
Sells
17
Buy Value
$330.83K
Distinct Buyers
1

Insider Score Trend Over Time

-55.0 since Aug 31
0255075100Aug 31 — Insider Score 55.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 43.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 31Sep 17Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.